Posted in | News | Nanomedicine | Nanomaterials

New Nanochain Targeted Delivery System for Effective Cancer Treatment

A research team led by Efstathios Karathanasis from the Case Western Reserve University has developed a novel nanochain targeted delivery system that delivers an anti-cancer medicine into hard-to-reach areas of tumor.

Test results on mice and rats proved that this nanotechnology destroyed more number of cancer cells; more effectively hindered the tumor growth; and enabled longer life when compared to conventional chemotherapy delivery. The nanochain delivery system also used a very little quantity of the drug doxorubicin when compared to conventional chemotherapy, thus reducing damage to healthy tissues.

In this novel delivery system, the research team chemically linked a tail made of three iron oxide magnetic nanoparticles to a liposome sphere containing the doxorubicin drug. This tail plays a key role in the system. To create the tail, the surfaces of the nanoparticles were modified so that the particles were able to attach with each other like Lego building blocks. The dosage of the drug in the liposome sphere is merely 5% to 10% of that utilized in traditional chemotherapy.

The research team injected the nanochains into the two rodents containing two different triple-negative breast cancer strains. Once the nanochains moved away from the blood stream and accumulated in the tumor site, the research team placed a solenoid outside the rodent models close to the tumor and passed an electric current through the solenoid to generate a radiofrequency field. This field made the magnetic nanoparticle tails to vibrate, causing the liposome spheres to break and release the drug into the tumor site.

The study results after a two-week treatment confirmed that the nanochain drug delivery system is more effective in treating cancer than traditional chemotherapy. The team also discovered that the drug release rate can be controlled by tuning the radiofrequency that causes the nanochain to vibrate. The team’s next step is to optimize the capability of the targeted drug delivery system to block the metastasizing capability of the tumor and to release drugs rapidly and efficiently. It will also assess the impact of shape and size of the nanochains on tumor penetration and blood circulation.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). New Nanochain Targeted Delivery System for Effective Cancer Treatment. AZoNano. Retrieved on October 06, 2024 from https://www.azonano.com/news.aspx?newsID=24697.

  • MLA

    Chai, Cameron. "New Nanochain Targeted Delivery System for Effective Cancer Treatment". AZoNano. 06 October 2024. <https://www.azonano.com/news.aspx?newsID=24697>.

  • Chicago

    Chai, Cameron. "New Nanochain Targeted Delivery System for Effective Cancer Treatment". AZoNano. https://www.azonano.com/news.aspx?newsID=24697. (accessed October 06, 2024).

  • Harvard

    Chai, Cameron. 2019. New Nanochain Targeted Delivery System for Effective Cancer Treatment. AZoNano, viewed 06 October 2024, https://www.azonano.com/news.aspx?newsID=24697.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.